Ambrosia Treatment Center Ambrosia of the Palm Beaches
-
Services:
- Early intervention for HIV
- Suicide prevention services
- Social skills development
- Domestic violence services, including family or partner
- Transportation assistance
- Mental health services
- Case management service
- Acupuncture
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Opioid use disorder clients only
- Private for-profit organization
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Health education services other than HIV/AIDS or hepatitis
- Hepatitis education, counseling, or support
- Marital/couples counseling
- Individual counseling
- Group counseling
- Family counseling
- HIV or AIDS education, counseling, or support
- Short-term residential
- Residential/24-hour residential
- Outpatient day treatment or partial hospitalization
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient detoxification
- Outpatient
- Regular outpatient treatment
- Long-term residential
- Residential detoxification
- Intensive outpatient treatment
- State department of health
- The Joint Commission
- Drug Enforcement Agency (DEA)
- State Substance use treatment agency
- State mental health department
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Cocaine Detoxification
- Opioids detoxification
- Methamphetamines detoxification
- Medication routinely used during detoxification
- STD testing
- Testing for Hepatitis B (HBV)
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- HIV testing
- TB screening
- Breathalyzer or blood alcohol testing
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Lofexidine
- Disulfiram
- Buprenorphine sub-dermal implant
- Buprenorphine with naloxone
- Medications for HIV treatment
- Clonidine
- Medications for pre-exposure to prophylaxis
- Acamprosate (Campral®)
- Medication for mental disorders
- Buprenorphine without naloxone
- Nicotine replacement
- Medications for Hepatitis C treatment
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Housing services
- Mentoring/peer support
- Self-help groups
- Employment counseling or training
- Assistance with obtaining social services
- Recovery coach
- Outreach to persons in the community
- Comprehensive mental health assessment
- Professional interventionist/educational consultant
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Interim services for clients
- Screening for tobacco use
- Screening for substance use
- Screening for mental disorders
- Smoking permitted in designated area
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Outcome follow-up after discharge
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Treatment for other addiction disorder
- Treatment for gambling disorder
- Young adults
- Pregnant/postpartum women
- Members of military families
- Active duty military
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients who have experienced sexual abuse
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Veterans
- Adult women
- Adult men
- Clients with HIV or AIDS
- Clients who have experienced trauma
- Clients with co-occurring mental and substance use disorders
- Clients with co-occurring pain and substance use disorders
- Seniors or older adults
- Clients who have experienced intimate partner violence, domestic violence
- Adolescents
- Female
- Male
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- Vaping permitted in designated area
- Private health insurance
- IHS/Tribal/Urban (ITU) funds
- Cash or self-payment
- Transitional housing, halfway house, or sober home
- Detoxification
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- In-network prescribing entity
- Relapse prevention with naltrexone
- Lofexidine or Clonidine detoxification
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine detoxification
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine maintenance
- In-network prescribing entity
- Trauma-related counseling
- Cognitive behavioral therapy
- Substance use disorder counseling
- Relapse prevention
- Motivational interviewing
- Contingency management/motivational incentives
- Matrix Model
- Brief intervention
- Telemedicine/telehealth therapy
- 12-step facilitation
- Anger management
- Children/Adolescents
Ancillary Services
Opioid Medications used in Treatment
Exclusive Services
Facility Operation (e.g., Private, Public)
Education and Counseling Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
License/Certification/Accreditation
Detoxification (medical withdrawal) Services
Testing
Pharmacotherapies
Recovery Support Services
Assessment/Pre-treatment
Facility Smoking Policy
Transitional Services
Type of Alcohol Use Disorder Treatment
Other Services
Special Programs/Groups Offered
Gender Accepted
Medical Services
Facility Vaping Policy
Payment/Insurance/Funding Accepted
Type of Care
External Source of Medications Used for Alcohol Use Disorder Treatment
Type of Opioid Treatment
External Opioid Medications Source
Treatment Approaches
Age Groups Accepted